Melanoma Lesion - Causes, Treatment & When to See a Doctor

```html

What is Melanoma Lesion?

Melanoma is a malignant (cancerous) tumor that arises from melanocytes, the cells that produce the pigment melanin. When these cells grow out of control, they can form a melanoma lesion – a spot, bump, or patch on the skin that may look like a mole or a new growth. Unlike most benign moles, melanoma can invade surrounding tissue and spread (metastasize) to other parts of the body, making early detection critical.

Melanoma accounts for only about 1% of skin cancers but is responsible for the majority of skin‑cancer deaths because of its aggressive nature. The disease can appear anywhere on the body, but it most commonly arises on sun‑exposed areas such as the back, legs, arms, and face. In some cases, melanoma may develop on mucous membranes (e.g., inside the mouth) or under the nails.

Sources: Mayo Clinic; CDC

Common Causes

Melanoma is not caused by a single factor; rather, a combination of genetic, environmental, and lifestyle influences increases risk. Below are the most frequently implicated causes and risk factors.

• Ultraviolet (UV) radiation exposure – Cumulative sun exposure and intermittent intense UV bursts (sunburns) damage DNA in melanocytes.
• Fair skin, red or blond hair, and light-colored eyes – Less melanin offers reduced natural protection against UV rays.
• Family history of melanoma – Genetic mutations (e.g., CDKN2A, BRAF) can be inherited.
• Personal history of melanoma or other skin cancers – Prior lesions increase the chance of new ones.
• Numerous or atypical moles (nevi) – Large, irregular, or dysplastic nevi are precursors in many cases.
• Immune suppression – Organ transplant recipients or patients on long‑term immunosuppressive therapy have higher rates.
• Exposure to artificial UV sources – Tanning beds emit UV‑A and UV‑B radiation linked to melanoma.
• Certain genetic syndromes – Conditions like xeroderma pigmentosum or familial atypical multiple mole melanoma (FAMMM) syndrome.
• Hormonal factors – Use of hormonal therapy, especially in women, may modestly elevate risk.
• Age – Incidence rises after age 30, with a peak in the 50‑70 age group.

Associated Symptoms

While many melanoma lesions are asymptomatic early on, certain accompanying signs may alert you to a problem.

• Itching, tenderness, or pain in the lesion.
• Bleeding or oozing from the spot.
• Change in color or uneven pigmentation (multiple shades of brown, black, red, white, or blue).
• Irregular borders – scalloped, ragged, or notched edges.
• Elevation or a raised surface compared with surrounding skin.
• Rapid growth or a “new” mole appearing after age 30.
• Surface crusting or a “pearly” appearance.
• Swelling of nearby lymph nodes (often in the neck, armpit, or groin).

Remember the ABCDE rule for early detection: Asymmetry, Border irregularity, Color variation, Diameter >6 mm, and Evolving lesion.

When to See a Doctor

Because melanoma can become life‑threatening if left untreated, it is essential to seek professional evaluation promptly if you notice any of the following:

• A new mole or pigmented spot after age 30.
• Any change in size, shape, color, or texture of an existing mole.
• Bleeding, ulceration, or crusting of a lesion.
• Persistent itching, tenderness, or pain.
• Growth of a mole on the scalp, soles of feet, palms, or under nails (acral melanoma).
• Unexplained swelling of nearby lymph nodes.

If you fall into a high‑risk group (family history, many atypical moles, previous melanoma, etc.), schedule routine skin examinations even when you have no visible changes.

Diagnosis

Accurate diagnosis hinges on a combination of visual assessment, dermatoscopic examination, and tissue sampling.

Clinical Skin Exam

During a skin‑cancer screening, your clinician will inspect your entire body, focusing on high‑risk locations, and may use the ABCDE criteria as a guide.

Dermoscopy

A handheld dermatoscope magnifies the lesion and reveals patterns not visible to the naked eye, improving detection of subtle melanoma features.

Biopsy Techniques

• Excisional biopsy – Entire lesion is removed with a narrow margin of normal skin; the gold standard for suspected melanoma.
• Punch biopsy – Small, round section taken; often used when the lesion is large or in a difficult location.
• Incisional biopsy – Part of a large lesion is removed for diagnosis.

The tissue is sent to a pathology laboratory, where a dermatopathologist assesses depth (Breslow thickness), ulceration, mitotic rate, and other prognostic factors.

Staging Work‑up (if melanoma is confirmed)

• Sentinel lymph‑node biopsy – determines if cancer has spread to nearby lymph nodes.
• Imaging studies (CT, PET, MRI) – used for advanced disease to locate metastases.
• Blood tests – baseline labs and, in some cases, lactate dehydrogenase (LDH) levels.

References: American Cancer Society; NIH

Treatment Options

Treatment is individualized based on tumor thickness, location, and whether it has spread. The primary goals are to remove the cancer completely and prevent recurrence.

Surgical Management

• Wide local excision – Removal of the melanoma with a margin of normal tissue (typically 1 cm for thin lesions, up to 2 cm for thicker cancers).
• Sentinel lymph‑node biopsy – Performed at the time of excision for tumors >0.8 mm thick; positive nodes may lead to complete lymph‑node dissection.

Targeted Therapy

For melanomas harboring specific genetic mutations (e.g., BRAF V600E/K), oral agents such as vemurafenib, dabrafenib, or combination therapy with MEK inhibitors (trametinib, cobimetinib) can shrink tumors and improve survival.

Immunotherapy

• Checkpoint inhibitors – Drugs like pembrolizumab, nivolumab (PD‑1 inhibitors) and ipilimumab (CTLA‑4 inhibitor) boost the body’s immune response against cancer cells.
• Adjuvant therapy – Given after surgery to reduce recurrence risk, especially in stage III‑IV disease.

Radiation Therapy

Rarely used as primary treatment but may be applied for in‑situ melanoma of the eye (uveal melanoma) or for palliation of metastatic sites.

Clinical Trials

Patients are encouraged to discuss participation in ongoing trials, which may provide access to novel agents or combination regimens.

Home & Supportive Care

• Wound care after surgery – keep incisions clean, follow your surgeon’s dressing instructions.
• Sun‑protection measures – broad‑spectrum sunscreen SPF 30+, protective clothing, and avoidance of peak UV hours.
• Regular skin self‑exams – monthly checks help catch new lesions early.
• Psychological support – counseling, support groups, or patient‑advocacy organizations (e.g., Melanoma Research Foundation).

For detailed treatment guidelines, see the NCCN Clinical Practice Guidelines.

Prevention Tips

While you cannot change genetic risk, most melanomas are linked to UV exposure, which is modifiable.

• Apply sunscreen – Use a broad‑spectrum SPF 30+ sunscreen every day, reapply every 2 hours and after swimming or sweating.
• Seek shade – Especially between 10 a.m. and 4 p.m., when UV intensity peaks.
• Wear protective clothing – Long‑sleeved shirts, wide‑brim hats, and UV‑protective sunglasses.
• Avoid indoor tanning – Tanning beds increase melanoma risk by up to 75%.
• Regular skin exams – Annual dermatology visits for high‑risk individuals; self‑exams monthly.
• Know your skin – Familiarize yourself with the pattern of your moles so you can spot new or changing lesions.
• Healthy lifestyle – A balanced diet rich in antioxidants (vitamins C, E, beta‑carotene) may support skin health, though evidence for direct melanoma prevention is limited.

Emergency Warning Signs

Key Take‑aways

Melanoma lesions are potentially deadly skin cancers that demand early detection and prompt treatment. Understanding risk factors, performing regular skin checks, and protecting your skin from UV radiation are the most effective strategies to reduce your risk. If you notice any suspicious changes, consult a dermatologist quickly; many melanomas are curable when caught early.

For more information, visit reputable resources such as the CDC, Mayo Clinic, or the World Health Organization.

```